Acquista Criptovalute
Paga con
USD
USD
Buy & Sell
Hot
Supports Visa, Mastercard, SEPA & more
P2P
0 Fees
Flexible trading, zero fees
Gate Card
Use your crypto for payments worldwide
Mercati
Trading
Basic
Advanced
Futures
Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Opzioni
Hot
Trade European-style Vanilla Options
Conto unificato
Massimizza l'efficienza del tuo capitale
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Guadagna
Lancia
CandyDrop
Raccogli le caramelle per guadagnare airdrop
Launchpool
Staking rapido, guadagna potenziali nuovi token
HODLer Airdrop
Fai holding GT e ottieni enormi airdrop gratuitamente
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Investimento
Square
Square
Post, share, and explore crypto trends
Live
moments live
Live crypto market analysis
Chat
Chat with crypto traders
News
What is happening in crypto
flower_head
Altro
Promozioni
AI
Altro
TradFi
WCTC S8
Rewards
COR

Prezzo Cencora Inc.

Closed
COR
$304,00
-$4,01(-1,30%)

*Data last updated: 2026-05-04 03:04 (UTC+8)

As of 2026-05-04 03:04, Cencora Inc. (COR) is priced at $304,00, with a total market cap of $59,13B, a P/E ratio of 38,97, and a dividend yield of 0,75%. Today, the stock price fluctuated between $303,79 and $310,38. The current price is 0,06% above the day's low and 2,05% below the day's high, with a trading volume of 1,35M. Over the past 52 weeks, COR has traded between $299,51 to $327,85, and the current price is -7,27% away from the 52-week high.

COR Key Stats

Yesterday's Close$308,01
Market Cap$59,13B
Volume1,35M
P/E Ratio38,97
Dividend Yield (TTM)0,75%
Dividend Amount$0,60
Diluted EPS (TTM)8,36
Net Income (FY)$1,55B
Revenue (FY)$321,33B
Earnings Date2026-05-06
EPS Estimate4,81
Revenue Estimate$81,08B
Shares Outstanding191,99M
Beta (1Y)0.718
Ex-Dividend Date2026-02-13
Dividend Payment Date2026-03-02

About COR

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distributes plasma and other blood products, vaccines, and other specialty pharmaceutical products; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; sales force services to manufacturers; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.
SectorHealthcare
IndustryMedical - Distribution
CEORobert Mauch
HeadquartersConshohocken,PA,US
Official Websitehttps://www.cencora.com
Employees (FY)51,00K
Average Revenue (1Y)$6,30M
Net Income per Employee$30,47K

Cencora Inc. (COR) FAQ

What's the stock price of Cencora Inc. (COR) today?

x
Cencora Inc. (COR) is currently trading at $304,00, with a 24h change of -1,30%. The 52-week trading range is $299,51–$327,85.

What are the 52-week high and low prices for Cencora Inc. (COR)?

x

What is the price-to-earnings (P/E) ratio of Cencora Inc. (COR)? What does it indicate?

x

What is the market cap of Cencora Inc. (COR)?

x

What is the most recent quarterly earnings per share (EPS) for Cencora Inc. (COR)?

x

Should you buy or sell Cencora Inc. (COR) now?

x

What factors can affect the stock price of Cencora Inc. (COR)?

x

How to buy Cencora Inc. (COR) stock?

x

Risk Warning

The stock market involves a high level of risk and price volatility. The value of your investment may increase or decrease, and you may not recover the full amount invested. Past performance is not a reliable indicator of future results. Before making any investment decisions, you should carefully assess your investment experience, financial situation, investment objectives, and risk tolerance, and conduct your own research. Where appropriate, consult an independent financial adviser.

Disclaimer

The content on this page is provided for informational purposes only and does not constitute investment advice, financial advice, or trading recommendations. Gate shall not be held liable for any loss or damage resulting from such financial decisions. Further, take note that Gate may not be able to provide full service in certain markets and jurisdictions, including but not limited to the United States of America, Canada, Iran, and Cuba. For more information on Restricted Locations, please refer to the User Agreement.

Other Trading Markets

COR
CFD
Fai trading

Cencora Inc. (COR) Latest News

2025-06-10 09:36

Union完成可信设置，为实现去信任跨链DeFi铺路

Gate News bot 消息，Union 创下零知识基础设施的新纪录，其 Groth16 可信设置仪式已结束，共收到 4,664 份已验证贡献，超越了 Manta Network 于 2023 年创下的纪录，另有 4,590 份贡献仍在等待中。这为使用简洁的有效性证明来验证共识和跨链消息奠定了加密基础。 可信设置仪式对于零知识证明系统至关重要。Union 使其能够充当“区块链中的区块链”，在以太坊、Cosmos、Arbitrum、Babylon 甚至比特币的 L2 层之间提供可验证的消息传递和资产转移，而无需依赖任何中心化参与者。 Union 首席技术官 Cor Pruijs表示：“Union 的 Groth16 可信设置仪式拥有史上最大规模，这意味着它拥有最小的诚实假设。” “诚实假设”是指为了确保最终加密参数的安全，参与者必须诚实行事（即不泄露或重复使用其私有随机数）的最小数量。 消息来源：Blockworks

2025-06-04 05:18

招银国际：升众安在线目标价至20.4港元 稳定币前景带来估值重估空间

Gate News bot 消息，招银国际发表研究报告指，随著香港稳定币条例将于今年生效，相信首批参与金管局稳定币发行商沙盒的公司将成为香港虚拟资产资金流动的主要受惠者，并为关联公司带来业绩上升的机会。 在保险方面，该行认为强劲的医疗和汽车保费带来的收入增长，以及CoR的改善将巩固利润结构。该行上调众安在线2025至27财年的每股盈测，分别至0.69、0.79及0.93元人民币，目标价由16港元调升至20.4港元，维持“买入”评级。 消息来源：金十

Hot Posts su Cencora Inc. (COR)

TechubNews

TechubNews

04-30 14:24
Quantum X Labs 于4月30日起以新的公司名称和股票代码"QXL"在纳斯达克开始交易。此次变更是在完成对全资子公司Quantum X Labs Ltd.的收购及企业品牌重塑后进行的，该公司正式确定了向以"量子计算"为核心的企业转型。 公司表示，未来将以量子计算、量子纠错、量子模拟、量子传感为核心业务，同时保留原有的数字广告业务。这是一种在保留现有收入基础的同时，强化下一代技术投资故事的架构。考虑到近期美国股市对人工智能(AI)和量子技术相关股票的兴趣日益增长，此次品牌重塑也被解读为提高市场关注度的策略。 公开的资产明细 公开的资产明细也引人注目。公司表示正在申请"AI-量子纠错"相关专利，并说明其持有涵盖量子陀螺仪、原子钟、模拟算法、网络安全、运输解码器、临床应用等领域的投资组合公司股权。量子纠错被认为是减少量子计算易受外部噪声影响这一弱点的核心技术。鉴于这是一个可能决定商业化竞争中实际性能的领域，其象征意义重大。 特别是原子钟和量子陀螺仪等量子传感技术，被提及有向国防、航空、自动驾驶、精确定位领域扩展的可能性。同时将投资组合扩展到模拟算法、网络安全、医疗/临床应用，这显示出公司正在尝试比单一技术更进一步的"生态系统型"方法。不过，公司提出的业务价值能否转化为实际销售额和商业合同，仍需另行验证。 更名的意义 此次更名不仅仅是简单的名称更换，更接近于重新确立企业身份。在纳斯达克上市公司中，以未来技术关键词为先导进行品牌重塑的案例并不少见，但市场最终还是会以技术成果和财务表现来评估。要让Quantum X Labs作为"量子计算"企业获得重新评估，其持有专利的进展、投资组合公司的业绩、以及与现有业务的平衡，预计将成为关键变量。 TP AI注意事项 本文基于TokenPost.ai语言模型进行摘要。正文主要内容可能被省略或与事实不符。
0
0
0
0
SleepTrader

SleepTrader

3 ore fa
* * * **Discover top fintech news and events!** **Subscribe to FinTech Weekly's newsletter** **Read by executives at JP Morgan, Coinbase, Blackrock, Klarna and more** * * * **CoreWeave to Invest Up to $23 Billion to Expand AI Infrastructure** --------------------------------------------------------------------- CoreWeave, a U.S.-based AI cloud hosting company, has announced plans to invest between $20 billion and $23 billion this year in expanding its AI infrastructure and data center capacity. **This significant capital infusion aims to cater to the growing demand for AI processing power**, particularly from clients like Microsoft, as reported by Reuters. The company’s CEO, Mike Intrator, discussed the ambitious investment strategy, noting that its unique approach to structuring debt and capital spending may take time for the market to fully understand.  **READ MORE: CoreWeave IPO Opens Below Expectations, Ends First Day Without Gains** **Massive Capital Expenditure Plans** ------------------------------------- CoreWeave’s capital expenditure for the second quarter of 2025 is projected to range between $3 billion and $3.5 billion. This is considerably higher than the company’s revenue expectations for the period, which are between $1.06 billion and $1.1 billion. **Despite these large capital expenditures, the company aims to maintain profitability while scaling its operations** to meet the demands of its rapidly expanding client base. Intrator also emphasized the company’s strategy to diversify its supply chains in light of the ongoing U.S.-China trade tensions, which could impact costs and logistics. **Impressive Revenue Growth and Challenges** -------------------------------------------- In its latest quarterly report, CoreWeave revealed a remarkable 420% increase in revenue for the quarter ending March 31, 2025. The company’s revenue surged to $188.7 million from $45.5 million in the same period last year. **Despite this impressive growth, CoreWeave also reported a widened net loss of $314.6 million**, up from $129.2 million the previous year. A significant portion of this loss was attributed to $177 million in stock-based compensation tied to the company's recent initial public offering (IPO). Despite the net loss, the company’s strong revenue performance highlights its growing presence in the AI infrastructure market. **CoreWeave’s Backlog and Key Deals** ------------------------------------- As of March 31, 2025, CoreWeave reported a revenue backlog of $25.9 billion, indicating strong future demand for its AI infrastructure services. **A major contributor to this backlog is a five-year agreement with OpenAI**, one of the leading AI research companies. The $11.9 billion deal will provide OpenAI with the necessary AI infrastructure, reinforcing CoreWeave’s position as a key player in the AI cloud hosting space. Additionally, as part of the agreement, OpenAI has agreed to invest $350 million in CoreWeave through the purchase of company stock, further strengthening the partnership between the two entities. **Looking Ahead: A Strong Position in the AI Market** ----------------------------------------------------- CoreWeave’s ambitious $23 billion investment plan underscores the company’s commitment to positioning itself as a leading provider of AI infrastructure services. By significantly expanding its data center capacity and bolstering its offerings to clients like Microsoft and OpenAI, CoreWeave aims to meet the increasing demand for AI-powered cloud hosting solutions. However, as the company navigates its growing pains, including high capital expenditure and ongoing losses linked to its IPO, CoreWeave will need to carefully balance its growth strategy with profitability. The market’s response to the company’s future plans, including the impact of its supply chain diversification efforts, will be key in determining its long-term success in the competitive AI infrastructure market.
0
0
0
0
NodeGuardian

NodeGuardian

05-03 02:35
Everest Group, Ltd. reported a significant increase in net income to $653 million in Q1 2026, up over 210% year-on-year, with a combined ratio strengthening to 91.2%. The improved financial performance was driven by lower pre-tax net catastrophe losses and strong contributions from underwriting and investment income. The Reinsurance Treaty business performed particularly well, achieving an 87.2% combined ratio, despite a decrease in gross written premium across the Group.
0
0
0
0